114 related articles for article (PubMed ID: 18690932)
1. NSAID use and the risk of Parkinson's disease.
Etminan M; Suissa S
Curr Drug Saf; 2006 Aug; 1(3):223-5. PubMed ID: 18690932
[TBL] [Abstract][Full Text] [Related]
2. NSAID use and risk of Parkinson disease: a population-based case-control study.
Becker C; Jick SS; Meier CR
Eur J Neurol; 2011 Nov; 18(11):1336-42. PubMed ID: 21457177
[TBL] [Abstract][Full Text] [Related]
3. NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study.
Brakedal B; Tzoulis C; Tysnes OB; Haugarvoll K
PLoS One; 2021; 16(9):e0256602. PubMed ID: 34492069
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study.
Etminan M; Carleton BC; Samii A
J Clin Neurosci; 2008 May; 15(5):576-7. PubMed ID: 18343119
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease.
Hernán MA; Logroscino G; García Rodríguez LA
Neurology; 2006 Apr; 66(7):1097-9. PubMed ID: 16606925
[TBL] [Abstract][Full Text] [Related]
6. Risk of Acute Cerebrovascular and Cardiovascular Events Among Users of Acetaminophen or an Acetaminophen-Codeine Combination in a Cohort of Patients with Osteoarthritis: A Nested Case-Control Study.
Roberto G; Simonetti M; Piccinni C; Lora Aprile P; Cricelli I; Fanelli A; Cricelli C; Lapi F
Pharmacotherapy; 2015 Oct; 35(10):899-909. PubMed ID: 26497476
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease.
Wahner AD; Bronstein JM; Bordelon YM; Ritz B
Neurology; 2007 Nov; 69(19):1836-42. PubMed ID: 17984451
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
Manthripragada AD; Schernhammer ES; Qiu J; Friis S; Wermuth L; Olsen JH; Ritz B
Neuroepidemiology; 2011; 36(3):155-61. PubMed ID: 21508649
[TBL] [Abstract][Full Text] [Related]
9. NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.
Samii A; Etminan M; Wiens MO; Jafari S
Drugs Aging; 2009; 26(9):769-79. PubMed ID: 19728750
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population.
Huerta C; Castellsague J; Varas-Lorenzo C; García Rodríguez LA
Am J Kidney Dis; 2005 Mar; 45(3):531-9. PubMed ID: 15754275
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study.
García Rodríguez LA; Walker AM; Pérez Gutthann S
Epidemiology; 1992 Jul; 3(4):337-42. PubMed ID: 1637896
[TBL] [Abstract][Full Text] [Related]
12. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
Etminan M; Lévesque L; Fitzgerald JM; Brophy JM
Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study.
Johnson AG; Simons LA; Simons J; Friedlander Y; McCallum J
Br J Clin Pharmacol; 1993 May; 35(5):455-9. PubMed ID: 8512757
[TBL] [Abstract][Full Text] [Related]
14. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
15. The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.
Mokhles MM; Trifirò G; Dieleman JP; Haag MD; van Soest EM; Verhamme KM; Mazzaglia G; Herings R; Luise Cd; Ross D; Brusselle G; Colao A; Haverkamp W; Schade R; Camp Gv; Zanettini R; Sturkenboom MC
Pharmacol Res; 2012 Mar; 65(3):358-64. PubMed ID: 22123498
[TBL] [Abstract][Full Text] [Related]
16. Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study.
Lee T; Lu N; Felson DT; Choi HK; Dalal DS; Zhang Y; Dubreuil M
Rheumatology (Oxford); 2016 Jun; 55(6):1099-105. PubMed ID: 26983451
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drugs and risk of Parkinson's disease in the elderly population: a meta-analysis.
Poly TN; Islam MMR; Yang HC; Li YJ
Eur J Clin Pharmacol; 2019 Jan; 75(1):99-108. PubMed ID: 30280208
[TBL] [Abstract][Full Text] [Related]
18. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease and colorectal cancer risk-A nested case control study.
Boursi B; Mamtani R; Haynes K; Yang YX
Cancer Epidemiol; 2016 Aug; 43():9-14. PubMed ID: 27232063
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
